Pentraxin 3 promotes microglial M2 polarization and excitatory synapse formation in the hippocampus in depression

This publication has 33 references indexed in Scilit:

• Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety
  CNS Drugs, 2024
• HMGB1/STAT3/p65 axis drives microglial activation and autophagy exert a crucial role in chronic Stress-Induced major depressive disorder
  Journal of Advanced Research, 2023
• Astrocytic Cebpd Regulates Pentraxin 3 Expression to Promote Fibrotic Scar Formation After Spinal Cord Injury
  Molecular Neurobiology, 2023
• Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
  Biomedicine & Pharmacotherapy, 2022
• Treatment-resistant depression with anhedonia: Integrating clinical and preclinical approaches to investigate distinct phenotypes
  Neuroscience & Biobehavioral Reviews, 2022
• Pentraxin 3: A promising therapeutic target for autoimmune diseases
  Autoimmunity Reviews, 2020
• Pentraxin 3 promotes long-term cerebral blood flow recovery, angiogenesis, and neuronal survival after stroke
  Journal of Molecular Medicine, 2018
• Deletion of fibroblast growth factor 22 (FGF22) causes a depression-like phenotype in adult mice
  Behavioural Brain Research, 2016
• Presynaptic size of associational/commissural CA3 synapses is controlled by fibroblast growth factor 22 in adult mice
  Hippocampus, 2015
• Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
  Molecular Neurobiology, 2015